title: Cancer immunotherapy: weak beats strong.
authors.affiliation: Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, 20251 Hamburg, Germany.|Institute for Tumor Biology, University Medical Center Hamburg-Eppendorf (UKE), University of Hamburg, 20246 Hamburg, Germany.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Deppert
authors.affiliation: Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, 20251 Hamburg, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Bruns
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000628:therapy; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; D061026:Programmed Cell Death 1 Receptor
keywords: Immune checkpoint blockade therapy; tumor antigen T-cell epitopes; tumor regression